Rockwell Medical, Inc. to Present at the 2021 LD Micro Invitational XI
03 juin 2021 07h00 HE
|
Rockwell Medical, Inc.
WIXOM, Mich., June 03, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management...
Rockwell Medical, Inc. Provides First Quarter 2021 Financial and Operational Update
17 mai 2021 16h05 HE
|
Rockwell Medical, Inc.
-Home Infusion FPC Program expected to initiate Phase 2 trial in second half of 2021- -Company received marketing approval in Canada for Triferic AVNU™- -Conference call and webcast on...
Rockwell Medical, Inc. to Report First Quarter 2021 Financial and Operating Results on May 17, 2021
03 mai 2021 07h00 HE
|
Rockwell Medical, Inc.
WIXOM, Mich., May 03, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and...
Rockwell Medical Announces Marketing Approval of Triferic® AVNU™ in Canada
27 avr. 2021 07h00 HE
|
Rockwell Medical, Inc.
WIXOM, Mich., April 27, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management...
Rockwell Medical Presents Data on Diagnosis and Management of Iron Deficiency Anemia in Home Parenteral Nutrition Patients at the NHIA 2021 Annual Conference
22 avr. 2021 16h05 HE
|
Rockwell Medical, Inc.
WIXOM, Mich., April 22, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management...
Rockwell Medical, Inc. Provides Fourth Quarter and Full Year 2020 Financial and Operational Update
31 mars 2021 16h05 HE
|
Rockwell Medical, Inc.
- 2020 revenue of $62.2 million - - Ended the year with $58.7 million in cash, cash equivalents and investments - - Conference call and webcast on Wednesday, March 31st at 4:30 p.m. ET - WIXOM,...
Rockwell Medical, Inc. to Report Fourth Quarter and Full Year 2020 Financial and Operating Results on March 31, 2021
18 mars 2021 07h00 HE
|
Rockwell Medical, Inc.
WIXOM, Mich., March 18, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management...
Rockwell Medical, Inc. to Present at the H.C. Wainwright Global Life Sciences Conference
04 mars 2021 07h00 HE
|
Rockwell Medical, Inc.
WIXOM, Mich., March 04, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management...
Rockwell Medical Announces U.S. Availability of Triferic® AVNU for Replacement of Iron and Maintenance of Hemoglobin in Patients on Hemodialysis
09 févr. 2021 07h00 HE
|
Rockwell Medical, Inc.
WIXOM, Mich., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management...
Rockwell Medical Announces Submission of Triferic® New Drug Application in South Korea by Partner, Jeil Pharmaceutical Co., Ltd.
01 févr. 2021 07h00 HE
|
Rockwell Medical, Inc.
WIXOM, Mich., Feb. 01, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and iron deficiency...